Latest News from Origin

Origin Capital News Q2 2017

Read about latest portfolio activity, performance data and the golf-day washout here.

Monica exit delivers 5.5x money at over 150% IRR

Origin is delighted to announce the sale of Monica Healthcare to global life sciences business GE Healthcare. Origin invested in Monica in November 2014, and again in March 2016. The exit has delivered over 5.5x returns to Origin and its co-investors, and the relatively short average holding period has lead to an exceptionally strong IRR.

Read more here..


ARM invests in Blu Wireless Technology

Origin portfolio company has secured a significant corporate investment from ARM, one of the world’s leading semiconductor technology companies. The investment is part of a wider strategic partnership – read more here…

Spectral Edge: Computational image processing – new investment

Spectral Edge is using computational techniques to combine visual spectrum and infra-red data from the same image. This can significantly improve clarity, detail and colour representation. Such improvements are much sought after by phone manufacturers and others. We participated in an early-stage round alongside institutional and angel investors.

Scancell realisation – 5.5x money

Scancell develops DNA-based vaccines for cancer therapy, and potentially other indications. We invested in the company in three separate funding rounds, in 2008, 2010 and 2011. We sold our holding in the latter half of 2015, realising just over 5.5x cost, equating to an IRR over the life of the investment of 37% pre-EIS benefits, or 44% including them.

Naturemetrics – New investment in genetic environmental monitoring

Naturemetrics is using DNA and other genetic approaches to assess the presence of organisms in natural environments. We have participated in a seed-funding round alongside the Iceni seedcorn fund and several individual angel investors.

Co-invest with Origin

Please contact us if you would like to discuss co-investing in our transactions. (Note: currently only possible in  unquoted investments, although we hope shortly to be able to offer quoted company co-investment also.)

Trakm8 – New AIM investment

Trakm8 provides vehicle telematics solutions for fleet operators and insurance company clients. We believe this market has significant growth potential and that Trakm8 has a strong competitive position and an impressive senior team.

Monica Healthcare: Strong progress and follow-on investment

We are delighted that since our original 2015 investment, Monica has agreed important commercial partnerships with GE Healthcare and Philips Health. These are the largest global suppliers of equipment in Monica’s clinical field of labour monitoring. We have recently participated in a top-up investment round.

1Spatial – New AIM investment

1Spatial is an AIM-quoted business that has developed sophisticated software used in geospatial data management. We are impressed by the quality and competitive strength of the company’s technology, and the potential of its commercial partnerships, and have recently invested in the company.